Amneal Pharmaceuticals, Inc. AMRX Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: Amneal Pharmaceuticals, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s finance lease liabilities?
- Amneal Pharmaceuticals, Inc. (AMRX) reported finance lease liabilities of $58.37M in Q4 2025.
- How has Amneal Pharmaceuticals, Inc.'s finance lease liabilities changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s finance lease liabilities decreased by 2.9% year-over-year, from $60.1M to $58.37M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s finance lease liabilities?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s finance lease liabilities has grown at a 96.3% compound annual growth rate (CAGR), from $2M to $58.37M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.